Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance
Open accessThe DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Acinetobacter baumannii : Emergence of a Successful Pathogen
Peleg, A. Y., Seifert, H., & Paterson, D. L. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-07 · Cited by 3,316
A functional classification scheme for beta-lactamases and its correlation with molecular structure
Bush, K., Jacoby, G. A., & Medeiros, A. A. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.6.1211 · Cited by 2,475
Falagas, M. E., Kasiakou, S. K., & Saravolatz, L. D. (2005) · Clinical Infectious Diseases · doi:10.1086/429323 · Cited by 1,744
Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology
Poirel, L., & Nordmann, P. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01456.x · Cited by 1,051
Maragakis, L. L., & Perl, T. M. (2008) · Clinical Infectious Diseases · doi:10.1086/529198 · Cited by 969
Comparative Genomics of Multidrug Resistance in Acinetobacter baumannii
Fournier, P.-E., Vallenet, D., Barbe, V., Audic, S., Ogata, H., Poirel, L., Richet, H., Robert, C., Mangenot, S., Abergel, C., et al. (2006) · PLoS Genetics · doi:10.1371/journal.pgen.0020007 · Cited by 812
The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii
Turton, J. F., Ward, M. E., Woodford, N., Kaufmann, M. E., Pike, R., Livermore, D. M., & Pitt, T. L. (2006) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2006.00195.x · Cited by 751
Turton, J. F., Woodford, N., Glover, J., Yarde, S., Kaufmann, M. E., & Pitt, T. L. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.01021-06 · Cited by 657
Magnet, S., Courvalin, P., & Lambert, T. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3375-3380.2001 · Cited by 575
Smith, M. G., Gianoulis, T. A., Pukatzki, S., Mekalanos, J. J., Ornston, L. N., Gerstein, M., & Snyder, M. (2007) · Genes & Development · doi:10.1101/gad.1510307 · Cited by 474
Garnacho‐Montero, J., Ortiz‐Leyba, C., Jimenez‐Jimenez, F. J., Barrero‐Almodovar, A. E., Garcia‐Garmendia, J. L., Bernabeu‐WittelI, M., Gallego‐Lara, S. L., & Madrazo‐Osuna, J. (2003) · Clinical Infectious Diseases · doi:10.1086/374337 · Cited by 470
Adams, M. D., Nickel, G. C., Bajaksouzian, S., Lavender, H., Murthy, A. R., Jacobs, M. R., & Bonomo, R. A. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00284-09 · Cited by 448
Comparative Genome Sequence Analysis of Multidrug-Resistant Acinetobacter baumannii
Adams, M. D., Goglin, K., Molyneaux, N., Hujer, K. M., Lavender, H., Jamison, J. J., MacDonald, I. J., Martin, K. M., Russo, T., Campagnari, A. A., et al. (2008) · Journal of Bacteriology · doi:10.1128/jb.00834-08 · Cited by 435
Ellis‐Grosse, E. J., Babinchak, T., Dartois, N., Rose, G., Loh, E., & Groups, T. 3. A. 3. C. S. (2005) · Clinical Infectious Diseases · doi:10.1086/431675 · Cited by 414
Multidrug-resistant Acinetobacter Infection Mortality Rate and Length of Hospitalization
Sunenshine, R. H., Wright, M.-O., Maragakis, L. L., Harris, A. D., Song, X., Hebden, J., Cosgrove, S. E., Anderson, A., Carnell, J., Jernigan, D. B., et al. (2007) · Emerging Infectious Diseases · doi:10.3201/eid1301.060716 · Cited by 411
Marchand, I., Damier-Piolle, L., Courvalin, P., & Lambert, T. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.9.3298-3304.2004 · Cited by 407
Falagas, M. E., Koletsi, P. K., & Bliziotis, I. A. (2006) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46747-0 · Cited by 399
Damier-Piolle, L., Magnet, S., Brémont, S., Lambert, T., & Courvalin, P. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00732-07 · Cited by 357
Lee, K., Yum, J. H., Yong, D., Lee, H. M., Kim, H. D., Docquier, J.-D., Rossolini, G. M., & Chong, Y. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4485-4491.2005 · Cited by 333
Lee, H.-W., Koh, Y. M., Kim, J., Lee, J.-C., Lee, Y.-C., Seol, S.-Y., Cho, D.-T., & Kim, J. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01842.x · Cited by 323
Regulation of Acinetobacter Baumannii Biofilm Formation
Gaddy, J. A., & Actis, L. A. (2009) · Future Microbiology · doi:10.2217/fmb.09.5 · Cited by 321
Comparative Analysis of Acinetobacters: Three Genomes for Three Lifestyles
Vallenet, D., Nordmann, P., Barbe, V., Poirel, L., Mangenot, S., Bataille, E., Dossat, C., Gas, S., Kreimeyer, A., Lenoble, P., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001805 · Cited by 314
Choi, C. H., Lee, E. Y., Lee, Y. C., Park, T. I., Kim, H. J., Hyun, S. H., Kim, S. A., Lee, S.-K., & Lee, J. C. (2005) · Cellular Microbiology · doi:10.1111/j.1462-5822.2005.00538.x · Cited by 301
Characterization of the Naturally Occurring Oxacillinase of Acinetobacter baumannii
Héritier, C., Poirel, L., Fournier, P.-E., Claverie, J.-M., Raoult, D., & Nordmann, P. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.10.4174-4179.2005 · Cited by 286
Afzal-Shah, M., Woodford, N., & Livermore, D. M. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.2.583-588.2001 · Cited by 282
Choi, C. H., Lee, J. S., Lee, Y. C., Park, T. I., & Lee, J. C. (2008) · BMC Microbiology · doi:10.1186/1471-2180-8-216 · Cited by 279
Mussi, M. A., Limansky, A. S., & Viale, A. M. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.4.1432-1440.2005 · Cited by 276
Iacono, M., Villa, L., Fortini, D., Bordoni, R., Imperi, F., Bonnal, R. J. P., Sicheritz-Ponten, T., De Bellis, G., Visca, P., Cassone, A., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01643-07 · Cited by 273
Falagas, M. E., Bliziotis, I. A., & Siempos, I. I. (2006) · Critical Care · doi:10.1186/cc4869 · Cited by 272
Héritier, C., Poirel, L., Lambert, T., & Nordmann, P. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3198-3202.2005 · Cited by 272
Biofilm formation by Acinetobacter baumannii.
Vidal, R., Domínguez, M., Urrutia, H., Bello, H., González, G., García, A., & Raúl Zemelman, Z. (1996) · PubMed · Cited by 271
Cephalosporinase over-expression resulting from insertion of ISAba1 in Acinetobacter baumannii
Héritier, C., Poirel, L., & Nordmann, P. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01320.x · Cited by 266
Ko, K. S., Suh, J. Y., Kwon, K. T., Jung, S.-I., Park, K.-H., Kang, C. I., Chung, D. R., Peck, K. R., & Song, J.-H. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm305 · Cited by 262
Tigecycline Efflux as a Mechanism for Nonsusceptibility in Acinetobacter baumannii
Peleg, A. Y., Adams, J., & Paterson, D. L. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01198-06 · Cited by 257
Biofilm formation in Acinetobacter baumannii: associated features and clinical implications
Rodríguez-Baño, J., Martí, S., Soto, S., Fernández-Cuenca, F., Cisneros, J. M., Pachón, J., Pascual, A., Martínez-Martínez, L., McQueary, C., Actis, L. A., et al. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01916.x · Cited by 248
Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report
Peleg, A. Y., Potoski, B. A., Rea, R., Adams, J., Sethi, J., Capitano, B., Husain, S., Kwak, E. J., Bhat, S. V., & Paterson, D. L. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl441 · Cited by 248
Bou, G., Oliver, A., & Martínez-Beltrán, J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.6.1556-1561.2000 · Cited by 247
Lo-Ten-Foe, J. R., de Smet, A. M. G. A., Diederen, B. M. W., Kluytmans, J. A. J. W., & van Keulen, P. H. J. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01406-06 · Cited by 242 · cited 1×
“Colistin resistance, particularly heteroresistance, has been reported [151,152] but can be difficult to detect using routine susceptibility testing methodologies [153], meaning current rates of resistance may be underestimated.”
BackgroundRuzin, A., Keeney, D., & Bradford, P. A. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm058 · Cited by 238
Poirel, L., Menuteau, O., Agoli, N., Cattoen, C., & Nordmann, P. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.8.3542-3547.2003 · Cited by 235
Betrosian, A. P., Frantzeskaki, F., Xanthaki, A., & Douzinas, E. E. (2008) · Journal of Infection · doi:10.1016/j.jinf.2008.04.002 · Cited by 230
Fernandez-Cuenca, F. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg097 · Cited by 229
Nemec, A. (2004) · Journal of Medical Microbiology · doi:10.1099/jmm.0.45716-0 · Cited by 226
Brown, S., Young, H. K., & Amyes, S. G. B. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.01016.x · Cited by 225
Petrosillo, N., Ioannidou, E., & Falagas, M. E. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.02061.x · Cited by 213
Lee, N.-Y., Lee, H.-C., Ko, N.-Y., Chang, C.-M., Shih, H.-I., Wu, C.-J., & Ko, W.-C. (2007) · Infection Control & Hospital Epidemiology · doi:10.1086/517954 · Cited by 198
Markou, N., Markantonis, S. L., Dimitrakis, E., Panidis, D., Boutzouka, E., Karatzas, S., Rafailidis, P., Apostolakos, H., & Baltopoulos, G. (2008) · Clinical Therapeutics · doi:10.1016/j.clinthera.2008.01.015 · Cited by 191
Michalopoulos, A., Fotakis, D., Virtzili, S., Vletsas, C., Raftopoulou, S., Mastora, Z., & Falagas, M. E. (2008) · Respiratory Medicine · doi:10.1016/j.rmed.2007.10.011 · Cited by 191
Kwa, A. L. H., Loh, C., Low, J. G. H., Kurup, A., & Tam, V. H. (2005) · Clinical Infectious Diseases · doi:10.1086/432583 · Cited by 191
GUARDABASSI, L., DIJKSHOORN, L., COLLARD, J.-M., OLSEN, J. E., & DALSGAARD, A. (2000) · Journal of Medical Microbiology · doi:10.1099/0022-1317-49-10-929 · Cited by 189
Impact of imipenem resistance on mortality in patients with Acinetobacter bacteraemia
Kwon, K. T., Oh, W. S., Song, J.-H., Chang, H.-H., Jung, S.-I., Kim, S.-W., Ryu, S. Y., Heo, S. T., Jung, D. S., Rhee, J.-Y., et al. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl499 · Cited by 188
Colistin Heteroresistance in Acinetobacter and Its Association with Previous Colistin Therapy
Hawley, J. S., Murray, C. K., & Jorgensen, J. H. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00766-07 · Cited by 183
Blot, S., Vandewoude, K., & Colardyn, F. (2003) · Intensive Care Medicine · doi:10.1007/s00134-003-1648-8 · Cited by 177
The epidemiology of antibiotic resistance
Gould, I. M. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.06.016 · Cited by 174
Acinetobacter baumannii outer membrane protein A targets the nucleus and induces cytotoxicity
Choi, C. H., Hyun, S. H., Lee, J. Y., Lee, J. S., Lee, Y. S., Kim, S. A., Chae, J.-P., Yoo, S. M., & Lee, J. C. (2007) · Cellular Microbiology · doi:10.1111/j.1462-5822.2007.01041.x · Cited by 166
Yum, J. H. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf043 · Cited by 163
Antimicrobial resistance in Europe and its potential impact on empirical therapy
Rossolini, G. M., & Mantengoli, E. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.02126.x · Cited by 160
Levin, A. S., Levy, C. E., Manrique, A. E. I., Medeiros, E. A. S., & Costa, S. F. (2003) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(02)00276-5 · Cited by 159
Adherence of Acinetobacter baumannii strains to human bronchial epithelial cells
Lee, J. C., Koerten, H. K., van den Broek, P., Beekhuizen, H., Wolterbeek, R., van den Barselaar, M., van der Reijden, T., van der Meer, J., van de Gevel, J. S., & Dijkshoorn, L. (2005) · Research in Microbiology · doi:10.1016/j.resmic.2005.09.011 · Cited by 157
Oliva, M. E., Rekha, A., Yellin, A. E., Pasternak, J., Campos, M., Rose, G. M., Babinchak, T., Ellis‐Grosse, E. J., Loh, E., & the 301 Study Group (2005) · BMC Infectious Diseases · doi:10.1186/1471-2334-5-88 · Cited by 153
Is IS ABA-1 customized for Acinetobacter ?
Segal, H., Garny, S., & Elisha, B. G. (2005) · FEMS Microbiology Letters · doi:10.1016/j.femsle.2005.01.005 · Cited by 153
Gordon, N. C., & Wareham, D. W. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn555 · Cited by 148
Self-citationSrinivasan, V. B., Rajamohan, G., & Gebreyes, W. A. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00748-09 · Cited by 145
Higgins, P. G., Wisplinghoff, H., Stefanik, D., & Seifert, H. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1586-1592.2004 · Cited by 142
Roca, I., Martí, S., Espinal, P., Martínez, P., Gibert, I., & Vilà, J. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00584-09 · Cited by 138
Siroy, A., Molle, V., Guillier, C., Vallenet, D., Pestel‐Caron, M., Cozzone, A. J., Jouenne, T., & Dé, E. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.12.4876-4883.2005 · Cited by 132
al Naiemi, N., Duim, B., Savelkoul, P. H. M., Spanjaard, L., de Jonge, E., Bart, A., Vandenbroucke‐Grauls, C. M. J. E., & de Jong, M. D. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.9.4862-4864.2005 · Cited by 132
Spread of blaCTX-M-type and blaPER-2 β-lactamase genes in clinical isolates from Bolivian hospitals
Celenza, G., Pellegrini, C., Caccamo, M., Segatore, B., Amicosante, G., & Perilli, M. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl055 · Cited by 130
Iron acquisition functions expressed by the human pathogen Acinetobacter baumannii
Zimbler, D. L., Penwell, W. F., Gaddy, J. A., Menke, S. M., Tomaras, A. P., Connerly, P. L., & Actis, L. A. (2009) · BioMetals · doi:10.1007/s10534-008-9202-3 · Cited by 129
Héritier, C., Poirel, L., Aubert, D., & Nordmann, P. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.1.268-273.2003 · Cited by 129
Principe, L., D’Arezzo, S., Capone, A., Petrosillo, N., & Visca, P. (2009) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/1476-0711-8-18 · Cited by 128
Redefining extended-spectrum -lactamases: balancing science and clinical need
Giske, C. G., Sundsfjord, A., Kahlmeter, G., Woodford, N., Nordmann, P., Paterson, D. L., Cantón, R., & Walsh, T. R. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn444 · Cited by 124
Wareham, D. W., Bean, D. C., Khanna, P., Hennessy, E., Krahé, D., Ely, A., & Millar, M. R. (2008) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-008-0473-y · Cited by 123
Self-citationParenteral and Inhaled Colistin for Treatment of Ventilator-Associated Pneumonia
Linden, P. K., & Paterson, D. L. (2006) · Clinical Infectious Diseases · doi:10.1086/504485 · Cited by 122
VEB-1 Extended-Spectrum β-lactamase–producing Acinetobacter baumannii, France1
Naas, T., Coignard, B., Carbonne, A., Blanckaert, K., Bajolet, O., Bernet, C., Verdeil, X., Astagneau, P., Desenclos, J., Nordmann, P., et al. (2006) · Emerging infectious diseases · doi:10.3201/eid1208.051547 · Cited by 122
Higgins, P. G., Wisplinghoff, H., Stefanik, D., & Seifert, H. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh427 · Cited by 120
Jang, T. N., Lee, S.-P., Huang, C., Lee, C.-L., & Chen, W.-Y. (2009) · Journal of Hospital Infection · doi:10.1016/j.jhin.2009.06.007 · Cited by 118
Erridge, C., Moncayo-Nieto, O. L., Morgan, R., Young, M., & Poxton, I. R. (2007) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46823-0 · Cited by 112
de Breij, A., Gaddy, J. A., van der Meer, J., Koning, R. I., Koster, A. J., van den Broek, P., Actis, L. A., Nibbering, P. H., & Dijkshoorn, L. (2009) · Research in Microbiology · doi:10.1016/j.resmic.2009.01.002 · Cited by 110
VEB-1 Extended-Spectrum β-lactamase–producingAcinetobacter baumannii, France
Naas, T., Coignard, B., Carbonne, A., Blanckaert, K., Bajolet, O., Bernet, C., Verdeil, X., Astagneau, P., Desenclos, J., Nordmann, P., et al. (2006) · Emerging infectious diseases · doi:10.3201/eid1708.051547 · Cited by 110
Attributable Mortality of Nosocomial Acinetobacter Bacteremia
Grupper, M., Sprecher, H., Mashiach, T., & Finkelstein, R. (2007) · Infection Control and Hospital Epidemiology · doi:10.1086/512629 · Cited by 107
Huys, G. R. B., Cnockaert, M. C., Vaneechoutte, M., Woodford, N., Nemec, A., Dijkshoorn, L., & Swings, J. (2004) · Research in Microbiology · doi:10.1016/j.resmic.2004.10.008 · Cited by 106
Siroy, A., Cosette, P., Seyer, D., Guillier, C., Vallenet, D., DORSSELAER, A. V., Boyer-Mariotte, S., Jouenne, T., & Dé, E. (2006) · Journal of Proteome Research · doi:10.1021/pr060372s · Cited by 106
VIM-1 Metallo-β-lactamase inAcinetobacter baumannii
Tsakris, A., Ikonomidis, A., Pournaras, S., TZOUVELEKIS, L. S., Sofianou, D., Legakis, N. J., & Maniatis, A. N. (2006) · Emerging infectious diseases · doi:10.3201/eid1206.051097 · Cited by 101
Houang, E. T. S., Chu, Y.-W., Lo, W. U., Chu, K. Y., & Cheng, A. F. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.4.1382-1390.2003 · Cited by 99
Saballs, M. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl274 · Cited by 93
Identification of an OprD Homologue in Acinetobacter baumannii
Dupont, M., Pagès, J., Lafitte, D., Siroy, A., & Bollet, C. (2005) · Journal of Proteome Research · doi:10.1021/pr050143q · Cited by 92
Cho, Y. J., Moon, D. C., Jin, J. S., Choi, C. H., Lee, Y. C., & Lee, J. C. (2009) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2009.02.010 · Cited by 91
Gounden, R., Bamford, C., van Zyl-Smit, R. N., Cohen, K., & Maartens, G. (2009) · BMC Infectious Diseases · doi:10.1186/1471-2334-9-26 · Cited by 80
Vahaboğlu, H., Öztürk, R., Özinel, M. A., Kocazeybek, B. S., Sahin, N., Korten, V., Tansel, Ö., Akalın, H., Tatman‐Otkun, M., Köksal, İ., et al. (2001) · Journal of Medical Microbiology · doi:10.1099/0022-1317-50-7-642 · Cited by 72
Dorsey, C. W., Beglin, M. S., & Actis, L. A. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.9.4188-4193.2003 · Cited by 72
Ribera, A., Roca, I., Ruiz, J., Gibert, I., & Vila, J. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg344 · Cited by 65
Bernabeu‐Wittel, M., Pichardo, C., García-Curiel, A., Pachón-Ibáñez, M. E., Ibáñez-Martínez, J., Me, J.-M., & Pachón, J. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01095.x · Cited by 64
Livermore, D. M., Hope, R., Brick, G., Lillie, M., Reynolds, R., & Surveillance, O. B. O. T. B. W. P. O. R. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn352 · Cited by 64
Presence of the Tet M Determinant in a Clinical Isolate of Acinetobacter baumannii
Feliu, A., Ruiz, J., & Vilà, J. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.7.2310-2312.2003 · Cited by 59
Szabó, D., Szentandrássy, J., Juhasz, Z., Katona, K., Nagy, K., & Rókusz, L. (2008) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/1476-0711-7-12 · Cited by 41
Alsultan, A. A., Hamouda, A., Evans, B. A., & Amyes, S. G. B. (2009) · Journal of Chemotherapy · doi:10.1179/joc.2009.21.3.290 · Cited by 40
Kim, S. A., Yoo, S. M., Hyun, S. H., Choi, C. H., Yang, S. Y., Kim, H., Jang, B. C., Suh, S. I., & Lee, J. C. (2008) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2008.00446.x · Cited by 33
Multidrug-Resistant Acinetobacter baumannii in New York City—10 Years Into the Epidemic
Morgan, D. J., Weisenberg, S. A., Augenbraun, M. H., Calfee, D. P., Currie, B. P., Furuya, E. Y., Holzman, R. S., Montecalvo, M. A., Phillips, M., Polsky, B., et al. (2009) · Infection Control and Hospital Epidemiology · doi:10.1086/593207 · Cited by 26
Cited by
Lee, C.-R., Lee, J. H., Park, M., Park, K. S., Bae, I. K., Kim, Y. B., Cha, C.-J., Jeong, B. C., & Lee, S. H. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00055 · Cited by 1,016
Acinetobacter baumannii: An emerging opportunistic pathogen
Howard, A., O’Donoghue, M., Feeney, A., & Sleator, R. D. (2012) · Virulence · doi:10.4161/viru.19700 · Cited by 837
Cai, Y., Chai, D., Wang, R., Liang, B., & Bai, N. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks084 · Cited by 557
Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models
McConnell, M. J., Actis, L., & Pachón, J. (2013) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2012.00344.x · Cited by 540
The Ecology, Biology and Pathogenesis of Acinetobacter spp.: An Overview
Doughari, H. J., Ndakidemi, P. A., Human, I. S., & Benade, S. (2011) · Microbes and Environments · doi:10.1264/jsme2.me10179 · Cited by 453
Metadata
- Authors
- Gordon, N. C., & Wareham, D. W.
- Venue
- International Journal of Antimicrobial Agents
- Publisher
- Elsevier BV
- Published
- 2010-03
- Volume
- 35
- Issue
- 3
- Pages
- 219-226
- ISSN
- 0924-8579 (ISSN-L)
- OpenAlex
- W2051221130
- Cited by
- 378
- References
- 99
- FWCI
- 12.34
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.